Urology & Continence · Full case

UTI in Women

NICE NG109Recurrent UTING12 haematuria

2 of 3 key signs = treatNon-pregnant woman with dysuria, new nocturia and cloudy urine and no vaginal discharge: 2 or more of these 3 key signs (UKHSA) → treat empirically without dipstick; dipstick adds little when symptoms are clear

Nitrofurantoin 1st-lineNitrofurantoin 100mg MR BD for 3 days is first-line for uncomplicated lower UTI in women (if eGFR ≥45). Trimethoprim only where local resistance is low and not in early pregnancy. Send culture if recurrent, pregnant, treatment fails, or atypical

Recurrent = ≥2 in 6mo / ≥3 in 1yrRecurrent UTI: ≥2 episodes in 6 months or ≥3 in 12 months. Triggers self-care advice, behavioural measures, vaginal oestrogen in post-menopausal women, and consideration of prophylaxis — and a haematuria/red-flag review

No dipstick if >65 / catheterDo NOT dipstick over-65s or catheterised patients: asymptomatic bacteriuria is common and a positive dipstick does not mean UTI. Diagnose on new urinary/systemic symptoms, not the stick. Avoid treating asymptomatic bacteriuria (except in pregnancy)

Pyelonephritis = systemicLoin pain, fever/rigors, nausea/vomiting → upper UTI (pyelonephritis): culture, 7–10 day antibiotic (e.g. cefalexin), and admit if septic, vomiting, pregnant, or not improving

Pregnancy = always treat & cultureIn pregnancy treat symptomatic UTI and asymptomatic bacteriuria (screen) — risk of pyelonephritis and pre-term birth. Avoid trimethoprim in 1st trimester (folate antagonist) and nitrofurantoin at term (neonatal haemolysis); always send culture

Visible haematuria 45+ = suspected cancer pathway referralUnexplained visible haematuria in a woman aged 45+ without UTI — or that persists/recurs after treating the UTI — is a NICE NG12 suspected bladder cancer pathway referral. Recurrent "UTIs" with blood need this excluded, not just re-treated

Vaginal cause?Vaginal discharge, itch or soreness points away from UTI toward thrush, BV or an STI; suprapubic pain with discharge raises PID. Always ask — dysuria is not always a UTI, especially in younger women

📋 Clinical Stem — UTI in Women

A 58-year-old post-menopausal woman with a fourth episode of cystitis this year, now frustrated and asking for "a standby antibiotic" — with a passing mention of pink urine

Janet Okafor, 58, attends with two days of burning on passing urine, going more often, and lower tummy discomfort. She says this is "the fourth time this year" and that antibiotics from the pharmacy or out-of-hours keep sorting it but it keeps coming back. She is post-menopausal (last period ~6 years ago), not sexually active currently, and otherwise well — no fever, no loin pain, no vomiting. When asked, she mentions the urine looked "a bit pink" on one occasion last month even after the antibiotics had finished. She would like "a few antibiotics to keep at home so I can start them whenever it flares."

This stem tests the ability to: confirm an uncomplicated lower UTI from focused symptoms (and know when a dipstick adds nothing); recognise this as recurrent UTI and shift from repeated reactive antibiotics to a structured plan (self-care, behavioural measures, vaginal oestrogen for a post-menopausal woman, and prophylaxis only after review); and — critically — not miss the red flag of visible haematuria persisting after UTI treatment in a woman over 45, which mandates a NICE NG12 suspected bladder cancer pathway referral. The SCA challenge is handling the request for standby/back-pocket antibiotics thoughtfully (antimicrobial stewardship) while still leaving Janet with a plan that addresses why it keeps recurring.

Scenario A — Uncomplicated lower UTI Young, non-pregnant woman, classic dysuria/frequency, no vaginal symptoms, no systemic features. Treat empirically (nitrofurantoin 3 days); self-care; safety-net for systemic features; no culture needed unless fails.

Scenario B — Recurrent UTI (this stem) ≥3 in a year. Confirm episodes (cultures where possible), review behavioural/self-care measures, vaginal oestrogen if post-menopausal, consider single-dose post-coital or continuous prophylaxis; exclude haematuria red flag and incomplete emptying.

Scenario C — Pyelonephritis Loin pain, fever/rigors, nausea/vomiting, systemically unwell. Send culture; broader/longer antibiotic (e.g. cefalexin 7–10 days); admit if septic, vomiting, pregnant or not improving.

Scenario D — UTI in pregnancy Always treat (symptomatic) and screen/treat asymptomatic bacteriuria; always culture; avoid trimethoprim in 1st trimester and nitrofurantoin at term; low threshold for review (pyelonephritis and pre-term birth risk).

Scenario E — "It's not a UTI" Dysuria with vaginal discharge/itch → thrush, BV or STI; suprapubic pain + discharge + deep dyspareunia → PID; sterile pyuria → consider chlamydia, TB, or non-infective cause. Dysuria is not always a UTI.

Key variables to adapt for Age (no dipstick >65; asymptomatic bacteriuria common); menopausal status (vaginal oestrogen for recurrence); pregnancy (always treat/culture, drug choice); systemic features (upper vs lower tract); haematuria (visible 45+ = suspected cancer pathway referral; persistent non-visible 60+ with dysuria/raised WCC = suspected cancer pathway referral); catheter (don't dipstick; treat only symptomatic); recurrence pattern; sexual history (STI mimic; post-coital trigger); comorbidity (diabetes, immunosuppression, stones — complicated UTI).

Steps:

Step 1

History — Confirm the UTI · Lower vs Upper · Recurrence · Red Flags · ICE

▲collapse

The history has three jobs: confirm this really is a urinary tract infection (and not a vaginal or sexually transmitted cause), decide whether it is lower (cystitis) or upper tract (pyelonephritis), and — because Janet has had several episodes — reframe it as recurrent UTI and screen for the things that drive recurrence and the things that masquerade as it. The single most important thread to pull is the "pink urine after the antibiotics finished": visible haematuria that persists after treating a UTI in a woman over 45 is a suspected cancer pathway referral red flag, not a feature of cystitis.

🎓 SCA framing — treat today's symptoms, but change the pattern

"I can sort out today's infection, and I also want to look at why it keeps coming back — because just reaching for antibiotics each time isn't really fixing the underlying problem for you. Can we do both?"

Janet wants standby antibiotics. The skill is to acknowledge her frustration and treat the episode, while moving the consultation toward the recurrence work-up (including the haematuria flag) rather than simply handing over a back-pocket prescription.

1A — Confirm the diagnosis and localise it

Question	Why it matters	Changes what?
🟢 OPEN QUESTION"Tell me what's been happening with your waterworks — and what's worrying you most about it coming back."	An open question lets you capture the symptom cluster and Janet's agenda (frustration, the wish for standby antibiotics) in one move. The UKHSA key signs of lower UTI in women under 65 are dysuria, new nocturia and urine cloudy to the naked eye; two or more of these in a non-pregnant woman without vaginal symptoms make UTI likely on history alone. With only one key sign plus other urinary symptoms (frequency, urgency, suprapubic tenderness, visible haematuria), a dipstick may support — but does not replace — clinical assessment.In SCA: gathering the cluster, the recurrence pattern, AND the agenda in the opening minute is what separates a strong data-gather from a checklist.	≥2 key signs (dysuria, new nocturia, cloudy urine), no vaginal symptoms → UTI likely
Lower vs upper tract"Any pain in your back or side, fevers, shivers, or feeling sick?"	Loin pain, fever/rigors, nausea/vomiting and systemic upset signal pyelonephritis (upper tract) — a different management track (culture, longer/broader antibiotic, possible admission). Janet has none of these — this is lower tract.Systemic features → pyelonephritis pathway. Confined to bladder symptoms → uncomplicated lower UTI.	Upper tract → 7–10 day antibiotic ± admission
Vaginal symptoms — the great mimic"Any discharge, itch, or soreness down below? Any chance of an STI?"	Vaginal discharge, itch or soreness shifts the differential to candida, bacterial vaginosis or an STI (chlamydia/gonorrhoea can cause dysuria with sterile pyuria). Suprapubic pain + discharge + deep dyspareunia raises PID. Dysuria is not always a UTI.Vaginal symptoms present → examine/swab; consider STI screen rather than reflex antibiotics.	Discharge/itch → vaginal/STI causeSTI screen if risk
Recurrence pattern"How many of these have you had this year? Were any confirmed with a urine sample? Any pattern — after sex, or at a particular time?"	Recurrent UTI = ≥2 in 6 months or ≥3 in 12 months. Janet meets this. Establishing whether episodes were culture-confirmed matters — some "recurrent UTIs" are actually unconfirmed dysuria from other causes. A post-coital pattern points to behavioural triggers and post-coital prophylaxis options.Recurrent → structured plan (self-care, vaginal oestrogen, prophylaxis) + red-flag review, not repeated reactive courses.	Recurrent → prevention strategy
🚩 Haematuria"You mentioned the urine looked pink — was that during the infection, or after the antibiotics had finished? Have you seen visible blood since?"	This is the safety core. Visible haematuria during an acute UTI can occur, but visible haematuria that persists or recurs after the UTI is treated, in a woman aged 45+, is a NICE NG12 suspected bladder cancer pathway referral. "Recurrent UTIs" is a classic context in which bladder cancer is missed because each episode is re-treated rather than investigated.Visible haematuria 45+ without UTI, or persisting after treatment → suspected bladder cancer pathway referral. Unexplained non-visible haematuria 60+ with dysuria or raised WCC (blood test) → suspected cancer pathway referral.	—Suspected bladder cancer pathway referral (NG12)
Complicating factors"Any chance you could be pregnant? Do you have diabetes, kidney problems, stones, or a catheter? Do you empty fully?"	Pregnancy, diabetes, immunosuppression, stones, structural abnormality, incomplete emptying or a catheter make a UTI "complicated" — changing investigation, drug choice and duration, and lowering the threshold for culture and referral. Incomplete emptying (post-void residual) is a treatable driver of recurrence.Complicating factors → culture, tailored antibiotic, consider imaging/urology; pregnancy → always treat and culture.	Culture; consider residual volume/imaging

1B — Red flags

🚨

Red Flags — when "another UTI" is something else

Red flag	Why dangerous	Action
Visible haematuria 45+ — without UTI, or persisting/recurring after UTI treatment	Bladder (and upper urinary tract) cancer commonly presents as painless visible haematuria and is repeatedly missed when blood is attributed to "recurrent cystitis." Janet (58, blood persisting after antibiotics) fits this exactly.	NICE NG12 suspected bladder cancer pathway referral; do not simply re-treat
Unexplained non-visible haematuria 60+ with dysuria or raised WCC	A separate NG12 threshold for bladder cancer; non-visible haematuria with these features warrants urgent referral rather than reassurance.	NICE NG12 suspected bladder cancer pathway referral
Sepsis / systemic upset (high/low temperature, tachycardia, hypotension, confusion)	Urosepsis — especially in the elderly, diabetic, immunosuppressed, pregnant, or obstructed (stone) — is life-threatening and can deteriorate rapidly.	Same-day admission; sepsis pathway; IV antibiotics
Pyelonephritis not responding / vomiting / pregnant	Upper-tract infection that cannot be managed orally, or in pregnancy, risks sepsis, pre-term labour and renal damage.	Admit / urgent assessment; IV antibiotics; obstetric input if pregnant
Recurrent UTI with the same organism, or stones / obstruction	Persistent same-organism infection suggests a focus (stone, incomplete emptying, structural abnormality) needing imaging and urology, not repeated short courses.	Culture; renal tract imaging; urology referral
Pneumaturia / faecaluria, or persistent symptoms with sterile pyuria	Pneumaturia/faecaluria suggests a colovesical fistula (diverticular disease, malignancy, Crohn's). Sterile pyuria suggests chlamydia, TB, stones or a non-infective cause.	Investigate cause; urology/colorectal referral; STI screen as indicated

1C — ICE

💭 Ideas

"What do you think is making it keep coming back?"

Janet may believe she is simply "prone to them" and that antibiotics are the only answer. Surfacing this lets you introduce the idea that recurrence has drivers (post-menopausal vaginal changes, behavioural factors, incomplete emptying) that can be addressed — and that the blood needs explaining, not just treating.

😟 Concerns

"Is there anything you've been worried it might be?"

She may be worried about kidney damage, about being on antibiotics repeatedly, or — quietly — about the blood. Eliciting this lets you frame the suspected cancer pathway referral as careful and routine ("because of your age and the blood I want a specialist to take a quick look, to be thorough") rather than frightening.

🎯 Expectations

"You mentioned wanting some to keep at home — tell me how you imagined that working."

The standby-antibiotic request is the SCA pivot. Some patients with proven recurrent culture-confirmed UTI do use standby or self-start regimens — but only after assessment and within a plan. Naming her expectation lets you offer a considered version (or a better alternative) rather than a flat yes/no.

1D — Psychosocial context

Recurrent UTIs are genuinely wearing: the pain, the disrupted sleep and work, the repeated trips for antibiotics, and the sense that nothing is fixing the underlying problem. That fatigue is what drives the standby-antibiotic request. A consultation that simply says "no" to that request — without offering a real plan to reduce recurrence — leaves the patient feeling unheard. The work here is to validate the frustration, treat today's episode, and put a structured prevention plan (and the necessary red-flag check) in its place.

🌸 Post-menopausal vaginal atrophy

After the menopause, falling oestrogen thins the vaginal and urethral tissues and changes the vaginal flora, which is a major and treatable driver of recurrent UTI. Vaginal oestrogen is one of the most effective preventive measures and is often overlooked.

"After the menopause the tissues down below get thinner and that makes infections more likely. A small amount of oestrogen cream or pessary used vaginally can really cut down how often these happen — it works locally and barely gets into the bloodstream."

💊 Antibiotic stewardship vs the standby request

Back-pocket antibiotics feel empowering but risk resistance and treating non-UTI symptoms. Offer instead: a clear self-care plan, a prevention strategy, and — if episodes are culture-confirmed and frequent — a properly set-up self-start or prophylaxis plan with review.

"I understand wanting something ready at home. Rather than antibiotics you start blindly, let me set up a proper prevention plan — and if we do go for standby antibiotics, I'd want to base it on what's actually grown on a urine test, so we hit the right bug."

💉 The blood — careful framing

The haematuria must be raised, but without alarm. Frame the referral as thoroughness given her age and the fact the blood outlasted the infection.

"One thing I don't want to overlook is that the urine was still pink after the antibiotics finished. In most people it's nothing serious, but at your age it's exactly the situation where I'd want a specialist to take a quick look to be on the safe side."

1E — PMH · drug history · social history: what changes management

Question	Why it matters	Changes what?
Previous cultures and antibiotics"Which antibiotics have you had for these, and did any urine tests come back? Have you had antibiotics in the last three months?"	NICE NG109 asks you to check previous urine culture and susceptibility results and recent antibiotic use before choosing a drug — both predict resistance. Four courses in a year from different providers means Janet is at real risk of a resistant organism, and it also means her record may be missing results held elsewhere (pharmacy or out-of-hours).Prior trimethoprim use or a trimethoprim-resistant culture makes trimethoprim a poor empirical choice today.	Drug choice guided by previous resultsMSU before today's dose
Where the antibiotics came from"Did you get these from the pharmacy each time, or from out-of-hours?"	The NHS Pharmacy First UTI pathway covers uncomplicated lower UTI in women aged 16 to 64, but excludes recurrent UTI (2 episodes in 6 months or 3 in 12 months), pregnancy and catheters. Once Janet reached the recurrence threshold she should have been signposted to general practice. That is not a criticism of anyone — it explains why nobody has yet looked at the pattern.	Recurrent → GP-led review, not repeat supplies
Renal function and interacting drugs"Any kidney problems? What medicines do you take — including anything for blood pressure, the heart, arthritis or psoriasis?"	Nitrofurantoin is recommended for lower UTI only if eGFR is 45 ml/min or more (NG109); the SPC allows cautious short-course use at 30–44 only for suspected or proven multidrug-resistant organisms. Trimethoprim can raise potassium and creatinine (caution with ACE inhibitors, ARBs, spironolactone, CKD) and should be avoided with methotrexate. Janet takes no regular medicines — but check the record, not just memory.	eGFR and interactions shape the drug
Breast cancer and hormone history"Have you ever had breast cancer, or been told to avoid hormones?"	Vaginal oestrogen is the key preventive step for a postmenopausal woman with recurrent UTI (NG112). After breast cancer, NICE NG23 advises non-hormonal moisturisers or lubricants first and, for women on an aromatase inhibitor, a decision with the breast cancer specialist. Ask before you offer.	Vaginal oestrogen: straightforward vs specialist discussion
Smoking and occupational exposures"Do you smoke, or have you ever? Any work with dyes, rubber or chemicals?"	Smoking is the strongest modifiable risk factor for bladder cancer, and historical occupational exposure to aromatic amines (dyes, rubber, leather industries) adds risk. Neither changes the NG12 referral decision — visible haematuria that persists after UTI treatment at 45+ is referred regardless — but they belong in the referral letter and give a natural route into smoking-cessation advice.	Include in suspected cancer pathway referral letter
Anticoagulants"Are you on any blood thinners?"	A common trap: haematuria in someone on an anticoagulant or antiplatelet is still investigated using the same NG12 thresholds. Anticoagulation may unmask a lesion; it does not explain the bleeding away.	Do not attribute haematuria to anticoagulation
Continence, bowels and fluid intake"Any leaking, difficulty emptying, or constipation? How much do you drink in a day?"	Incomplete emptying, constipation, incontinence and low fluid intake are reversible drivers of recurrent UTI named in the NG112 work-up. Some women deliberately drink less to reduce frequency or leakage — which concentrates the urine and can make recurrence more likely.	Behavioural plan; bladder scan if residual suspected

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases that score

"Was the pink urine during the infection or after the antibiotics had finished?" — the question that opens the red-flag door.

"Let's treat today's infection and also look at why it keeps coming back — including whether a little vaginal oestrogen would help." — moves from reactive to preventive.

"Any back pain, fevers or feeling sick?" — localises upper vs lower tract.

Deductions

Attributing the persistent blood to "recurrent cystitis" and not referring (suspected cancer pathway)
Handing over standby antibiotics with no assessment or plan
Not asking about vaginal symptoms (the mimic) or recurrence pattern
Forgetting vaginal oestrogen in a post-menopausal woman

🔴 Red

Haematuria red flag missed; standby antibiotics given uncritically; no upper/lower distinction; vaginal mimic not considered

🟠 Amber

UTI treated; recurrence acknowledged but no prevention plan; blood noted but referral not made; ICE partial

🟢 Green

UTI confirmed and localised; recurrent UTI named with prevention plan (self-care, vaginal oestrogen, considered prophylaxis); haematuria → suspected cancer pathway referral; ICE all three; stewardship handled empathetically; safety-net

Step 2

Triage — Sepsis · Pyelonephritis · suspected cancer pathway referral · Routine

▲collapse

Most lower UTI in women is managed in a single primary-care contact. The triage task is to pull out urosepsis and pyelonephritis needing urgent/secondary care, the haematuria that needs a suspected cancer pathway referral, and to recognise pregnancy and the frail elderly as special cases. Janet is systemically well — but her persistent visible haematuria places her in the urgent-referral lane regardless of how routine the infection itself looks.

🔴 Emergency

Same day / 999

Immediate action

UrosepsisFever/rigors + tachycardia/hypotension/confusion → admit; sepsis six; IV antibiotics
Pyelonephritis — vomiting / not coping / pregnantUnable to tolerate oral, or pregnant → admit / urgent assessment
Obstructed infected system (stone)Loin pain + fever + obstruction → urological emergency (decompression)

🟠 Urgent / Refer

Suspected cancer pathway referral & specialist

Urgent (days)

Visible haematuria 45+ (no UTI / persists after treatment)NICE NG12 suspected bladder cancer pathway referral
Non-visible haematuria 60+ with dysuria / raised WCCNICE NG12 suspected bladder cancer pathway referral
Recurrent UTI with focus / treatment failureRenal tract imaging; urology referral

🟢 Routine

GP Management

Primary care first-line

Uncomplicated lower UTIEmpirical antibiotic (nitrofurantoin 3 days); self-care; safety-net
Recurrent UTI preventionSelf-care; vaginal oestrogen; consider prophylaxis after review
Possible vaginal/STI causeExamine/swab; STI screen rather than reflex antibiotics

🎓 SCA Checkpoint — Step 2Tasks

Triage rationale

"The infection itself is the kind we treat here and you're not systemically unwell — but the blood that stayed after the last course means I should refer you on a fast-track pathway to be safe."

Deductions

Missing the haematuria trigger for a suspected cancer pathway referral amid a "routine" UTI
Not recognising pregnancy / frailty / sepsis as different tracks

Step 3

Examination — Targeted · Abdomen · Loins · Vaginal Assessment if Indicated

▲collapse

Examination in straightforward lower UTI is brief — observations and abdomen — but it earns its place by separating lower from upper tract (loin tenderness, temperature) and by picking up the things that change the plan: a vaginal cause, a palpable bladder (retention/incomplete emptying), or systemic upset.

⚕️ What to examine

Step	Why
Observations	Temperature, pulse, BP — screen for systemic infection/sepsis; afebrile and stable supports uncomplicated lower UTI.
Abdomen	Suprapubic tenderness (cystitis); a palpable, distended bladder suggests retention/incomplete emptying — a driver of recurrence.
Loins (renal angles)	Tenderness suggests pyelonephritis (upper tract) — changes antibiotic and duration.
Vaginal assessment (if vaginal symptoms / atypical)	Look for atrophic changes (post-menopausal — vaginal oestrogen), discharge (candida/BV/STI), and cervical signs; examine and swab rather than reflex-prescribe.

⚠️ Dipstick — use it correctly

Under 65, clear symptoms: a dipstick adds little — treat on symptoms. Where the history is less clear (UKHSA): nitrite positive, or leucocyte and blood positive → UTI likely; leucocyte positive but nitrite negative → UTI as likely as another cause, send a culture; all three negative → UTI less likely.

Do NOT dipstick over-65s or catheterised patients: asymptomatic bacteriuria is common, and a positive stick does not mean infection — diagnose on new urinary/systemic symptoms.

Send culture (MSU) when: recurrent, pregnant, treatment failure, atypical, systemically unwell, or before prophylaxis.

🎓 SCA Checkpoint — Step 3TasksGlobal Skills

Narration that scores

"I'll check your temperature and feel your tummy and the small of your back, and given the recurrence I'd like to send a urine sample to the lab and consider examining for any vaginal changes that could be contributing."

Deductions

Dipsticking an over-65 / catheter and treating asymptomatic bacteriuria
Not checking loins / observations before calling it "lower UTI"

Step 4

Investigations — Culture · Recurrence Work-up · The Red-Flag Pathway

▲collapse

Uncomplicated UTI needs no investigation beyond (sometimes) a dipstick. Investigations are reserved for recurrence, treatment failure, pregnancy, systemic illness and the red-flag pathway. For Janet, the two priorities are a culture (to guide any future self-start/prophylaxis) and the suspected bladder cancer pathway referral for the persistent haematuria.

🧪 Tests — targeted

Test	When
Midstream urine culture	Recurrent UTI, pregnancy, treatment failure, atypical features, systemically unwell, or before starting prophylaxis — identifies organism and sensitivities.
Bloods (FBC, U&E, CRP)	If systemically unwell / pyelonephritis / sepsis; renal function relevant to nitrofurantoin (avoid if eGFR <45; SPC allows a cautious short course at 30–44 only for multidrug-resistant organisms).
Fasting glucose / HbA1c	Recurrent UTI can unmask diabetes; worth checking in recurrence.
Post-void bladder scan	If incomplete emptying suspected (palpable bladder, recurrence) — a treatable driver.
🚩 Suspected cancer pathway referral / urology imaging	Visible haematuria 45+ (NG12 bladder cancer); recurrent UTI with focus → renal tract USS/CT and cystoscopy via urology.

🔁 Recurrent UTI work-up

Confirm episodes are genuine UTIs (cultures), identify drivers: post-menopausal atrophy, incomplete emptying, constipation, dehydration, sexual activity, spermicide/diaphragm use, diabetes.

Exclude red flags (haematuria) and a structural focus (same-organism reinfection, stones).

Then build a prevention plan (Step 7) — escalating from self-care and vaginal oestrogen to prophylaxis only where justified.

🎓 SCA Checkpoint — Step 4Tasks

Key reasoning

"I'll send a urine sample to the lab so any future treatment targets the right bug, check your kidney function and sugar, and refer you on a fast-track pathway for the blood."

Deductions

Ordering nothing in recurrent UTI (no culture to guide prophylaxis)
Reflex broad investigations with no rationale ("data slop")
Missing the haematuria pathway

Step 5

Diagnosis — Uncomplicated vs Complicated · Recurrent · The Mimics

▲collapse

The diagnostic step names the tract (lower vs upper), the category (uncomplicated, complicated, recurrent), and consciously holds open the mimics — vaginal/STI causes, and the bladder cancer that hides behind "recurrent UTI."

Diagnosis	Discriminating features
Uncomplicated lower UTI	Healthy non-pregnant woman; dysuria/frequency/urgency; no systemic features; no complicating factors.
Recurrent UTI	≥2 in 6 months / ≥3 in 12 months; needs prevention strategy + red-flag review (Janet).
Pyelonephritis (upper UTI)	Loin pain, fever/rigors, nausea/vomiting, systemic upset.
Complicated UTI	Pregnancy, diabetes, immunosuppression, stones, structural/functional abnormality, catheter, male sex.
Vaginal / STI cause	Discharge, itch, soreness, dyspareunia; sterile pyuria; consider candida, BV, chlamydia/gonorrhoea, PID.
🚩 Bladder / urinary tract cancer	Visible haematuria 45+ (or persisting after UTI), painless haematuria, or recurrent same-organism infection with a focus — NG12 pathway.

🚩 The masquerader — bladder cancer behind "recurrent cystitis"

The most important diagnostic discipline in recurrent UTI is to ask, every time, whether the blood and the recurrence have actually been investigated — or just re-treated. In a woman over 45 with visible haematuria that outlasts the infection, the working assumption must include bladder cancer until a suspected cancer pathway assessment excludes it. For Janet, the working diagnosis is recurrent lower UTI plus an unexplained persistent haematuria that needs urgent referral in parallel.

🎓 SCA Checkpoint — Step 5Tasks

Explaining it plainly

"You've got another bladder infection, and the pattern tells me these are recurring — so we'll both treat it and prevent it. Separately, because of the blood that stayed afterwards, I want a specialist to check your bladder to be safe."

Deductions

Diagnosing "recurrent UTI" while leaving the haematuria unexplained
Missing a vaginal/STI cause of dysuria

Step 6

Referral — suspected cancer pathway referral · Urology · Obstetrics · When to Escalate

▲collapse

Most UTI never needs referral. Referral is for the red-flag haematuria (suspected cancer pathway), the recurrent UTI with a focus, the complicated/obstructed system, and pregnancy. State the cancer threshold precisely.

Referral	Who / when	Urgency
🟣 Bladder cancer (suspected cancer pathway)	Visible haematuria 45+ without UTI, or that persists/recurs after UTI treatment; non-visible haematuria 60+ with dysuria or raised WCC.	Suspected cancer pathway referral · NICE NG12
Urology	Recurrent UTI with a focus (stones, incomplete emptying, structural abnormality), same-organism reinfection, or treatment failure; suspected fistula.	Routine / soon
Obstetrics	UTI/pyelonephritis in pregnancy not settling, or asymptomatic bacteriuria management concerns.	Urgent by severity
Sexual health / GUM	Suspected STI cause of dysuria, or PID needing assessment and partner notification.	Routine / soon
🔴 Acute admission	Urosepsis; pyelonephritis with vomiting/pregnancy/not coping; obstructed infected system.	Same day

🎓 SCA Checkpoint — Step 6Tasks

Stating the threshold

"Because you're over 45 and the blood was visible and outlasted the infection, the guidance is to refer you on the urgent suspected cancer pathway so the bladder can be checked promptly."

Deductions

Not naming/actioning the NG12 haematuria pathway
Repeatedly re-treating recurrent same-organism UTI without urology

Step 7

Management — Expectation · Goals · Self-Care · Prescribing · Drug Cards · Psychosocial · Follow-Up · Monitoring · Safety-Netting

▲collapse

Management has two halves: treat today's infection appropriately, and put a structured prevention plan in place so Janet is not back next month. Antimicrobial stewardship runs through both — the right drug, the right duration, and prophylaxis only where justified.

7A — Address the patient's expectation first: validate → explain → negotiate

🤝

Janet wants a stash of antibiotics — acknowledge it, share your reasoning, then agree a plan that actually reduces the infections

Validate — name the request and the frustration

Janet's request is reasonable from where she sits: four infections, four courses, and each time the antibiotic "worked". What she is really asking for is control — not having to chase a prescription while in pain. Naming both the request and the frustration before responding stops the consultation turning into a bargaining match over a prescription.

"Four infections in a year is miserable, and I can see why having antibiotics at home feels like the answer — you'd be in control rather than chasing a prescription each time. Let me tell you what I'm thinking, because I want to get you to fewer infections, not just faster treatment."

Explain — why a blind stash is not the best tool yet

Several episodes were never cultured, so we do not know which bug she has or what it is sensitive to. Repeated courses breed resistance, and a self-started antibiotic can mask the one thing that must not be masked: the blood. NICE NG112 sets out a prevention ladder — behavioural measures, vaginal oestrogen after the menopause, then single-dose or non-antibiotic options, with daily antibiotic prophylaxis last. A standby supply is not a rung on that ladder for most women; if ever used, it should rest on culture results and a clear plan.

"Only a couple of your infections were tested, so I don't know which germ keeps coming back or which antibiotic actually suits it. If I hand you a supply now, we're guessing — and the next one might not work. There are also things that stop these happening in the first place, and after the menopause one of them works particularly well."

Negotiate — give her something concrete today

Janet must leave with more than a refusal: treatment for today's infection with a urine sample sent first; vaginal oestrogen started; a written self-care and prevention plan; the fast-track referral for the blood explained calmly; and a named route back if she gets symptoms again ("ring and say 'recurrent UTI plan' — we'll see you and send a sample the same day"). Offer to revisit a culture-guided standby or prophylaxis plan once the referral and prevention steps are in place.

"Here's my offer: I'll treat today's infection and send the urine to the lab first, start a vaginal oestrogen to cut down how often these happen, give you a written plan, and arrange for the bladder to be checked because of the blood. If you still get infections once that's in place, we'll look again at a longer-term option — based on what the lab has grown."

Key principle: Stewardship and patient-centredness are not in conflict here. The evidence is on the prevention side — the NG112 ladder reduces infections, whereas a standby supply only shortens the wait for the next one. The pivot is to reframe Janet's goal from "faster antibiotics" to "fewer infections", then show her the plan that achieves it. Refusing without an alternative loses the Relating to Others marks; handing over a stash without assessment loses the Tasks marks.

7B — Why treatment matters: goals tailored to Janet

≥45

Visible haematuria that persists or recurs after successful UTI treatment → urgent suspected cancer referral — NICE NG12. Janet is 58.

≥2 / 6 mo · ≥3 / 12 mo

NICE NG112 definition of recurrent UTI — the trigger for a work-up and prevention plan rather than another reactive course

3 days

Nitrofurantoin 100 mg MR twice a day for a non-pregnant woman with lower UTI, if eGFR ≥45 — NICE NG109

48 hours

Reassess if not starting to improve within 48 hours of the antibiotic, or sooner if worse — NG109 (and NG111 for pyelonephritis)

eGFR 45

Threshold for nitrofurantoin in NG109; SPC allows a cautious short course at 30–44 only for suspected or proven multidrug-resistant organisms

12 months

Review vaginal oestrogen for recurrent UTI within 12 months, or earlier if agreed — NICE NG112

6 months

Review methenamine hippurate or antibiotic prophylaxis within 6 months (methenamine then every 12 months) — NICE NG112 (2024)

28 days

NHS England Faster Diagnosis Standard — cancer diagnosed or ruled out within 28 days of an urgent suspected cancer referral

Treatment goals for Janet

Today's infection treated with the right drug for the right length (3 days, eGFR-appropriate)Urine culture sent before the first dose — the foundation for every future decision Haematuria explained: urgent suspected cancer referral made and understood, not frighteningUrinalysis after treatment to document whether blood persists Fewer infections: behavioural measures + vaginal oestrogen now; NG112 ladder if not enoughReversible drivers checked: emptying, constipation, fluids, HbA1c Janet understands the red flags for kidney infection and sepsisA clear route back — same-day sample and review for the next episode

Motivational language — tailored to Janet

"You've spent a year firefighting these. What I'd like is for us to spend the next few months fireproofing — so that by the summer you're thinking about infections a lot less, not just treating them faster."

"The check on your bladder is about being thorough. Most of the time it finds nothing serious — but if there is something, finding it early is exactly what we want, and the fast-track pathway is designed to get you an answer within a few weeks."

7C — Non-medication management: mechanism + evidence + tailored advice

NICE NG112 puts behavioural and personal hygiene measures on the first rung of recurrent UTI prevention, and NG109 makes self-care part of every acute episode. Be honest about the strength of the evidence: fluids and self-care are sensible and low-risk; cranberry and D-mannose have limited or uncertain evidence and NG109 notes there is no evidence to support cranberry products or urine alkalinising agents for treating an acute lower UTI.

💧

Fluids & Not Delaying Voiding

Target: pale-straw urine through the day; void when the urge comes

Mechanism

Regular urine flow dilutes and flushes bacteria that ascend the urethra before they can establish in the bladder. Holding on for long periods and concentrated urine both favour bacterial growth.

Practical

Drink enough to avoid dehydration (NG109 / NG112 self-care advice). Many women with frequency or leakage cut their fluid intake — explore this, because it can feed the cycle. Spread drinks through the day and ease off in the two hours before bed if nocturia is a problem.

NG112 rung 1 — low cost, low risk; evidence for increased water intake mainly in premenopausal women

🚽

Complete Emptying & Bowels

Target: soft daily stool; no significant post-void residual

Mechanism

Residual urine is a reservoir for bacteria. Constipation raises pelvic pressure, impairs bladder emptying and increases perineal bacterial load. Prolapse can also cause incomplete emptying after the menopause.

Practical

Ask about straining, a feeling of incomplete emptying, a vaginal lump or dragging. Treat constipation (fibre, fluids, laxative if needed). Consider a bladder scan for post-void residual if emptying is in doubt; "double voiding" (wait a minute, then try again) helps some women.

Named reversible drivers in the NG112 work-up — fix before prophylaxis

🌸

Genitourinary Syndrome of Menopause

Target: vaginal oestrogen started; moisturiser for comfort

Mechanism

Oestrogen loss thins the vaginal and urethral lining, raises vaginal pH and depletes protective lactobacilli, allowing gut-derived uropathogens to colonise the vaginal introitus and periurethral area.

Practical

This card is the non-drug half: vaginal moisturisers and lubricants help comfort and are the first step after breast cancer (NG23). The effective prevention step is vaginal oestrogen itself (see 7D and 7F). Oral or systemic HRT does not reduce UTI risk and should not be offered for that purpose (NG112).

Vaginal oestrogen reduced recurrent UTI in postmenopausal women in the NG112 evidence review

❤️

Sex-Related Triggers

Target: identify and remove the trigger

Mechanism

Intercourse massages periurethral bacteria into the bladder. Spermicides disrupt the vaginal flora and favour E. coli colonisation; a diaphragm can also impede emptying.

Practical

Janet is not currently sexually active, so this is for completeness — but ask, because circumstances change and a post-coital pattern changes the plan. Advice: pass urine after sex, avoid spermicide-containing contraception, use lubricant if dryness. If a clear post-coital pattern persists, NG112 allows single-dose antibiotic prophylaxis at the trigger.

A clear trigger unlocks single-dose prophylaxis — far less antibiotic than nightly dosing

🍒

Cranberry & D-Mannose — Honest Advice

Target: informed choice, not false hope

Mechanism

Cranberry proanthocyanidins and D-mannose are thought to reduce the adhesion of E. coli fimbriae to the bladder lining.

Practical

NG112 describes the evidence for prevention as limited or uncertain; some women choose to try them, and that is reasonable if they understand this. They are not a treatment for an active infection (NG109). Cranberry products can be sugary, and there are case reports of interaction with warfarin — check before endorsing.

Patient choice — not a substitute for vaginal oestrogen or a culture

⚕️

Acute-Episode Self-Care

Target: symptom relief within days; know when to escalate

Mechanism

Lower UTI symptoms are driven by bladder-wall inflammation. Analgesia and hydration relieve symptoms while the antibiotic — or, in mild cases, the body — clears the infection.

Practical

Paracetamol, or ibuprofen if suitable (NG109). Keep a simple symptom diary for each episode — date, symptoms, whether a sample was sent and the result — so the next consultation starts with evidence rather than memory. Record any visible blood and when it happened relative to the antibiotic.

Symptom diary turns "four UTIs" into a pattern you can act on

7D — Prescribing guide: NICE NG109 · NG111 · NG112 — right drug, right length, right tier

Doses and durations below are those stated in the named guideline (NICE NG109, NG111 or NG112); anything else is "dose per SPC". Always check previous culture results and recent antibiotic use first, and follow local antimicrobial guidance where it differs. For Janet today: send an MSU, then nitrofurantoin 100 mg MR twice a day for 3 days if her eGFR is 45 or more — and choose on her previous culture if one showed nitrofurantoin resistance.

Situation	Regimen (as stated in the guideline)	Key points
Lower UTI, non-pregnant woman — strategyNICE NG109	Consider a back-up prescription (start if not improving within 48 hours or worse at any time) or an immediate prescription, taking account of symptom severity, risk of complications, previous culture results and previous antibiotic use.	For Janet (recurrent, symptomatic today, culture being sent) an immediate prescription is a reasonable clinical choice. Self-care for all.
Lower UTI — first choiceNG109, 3 days	Nitrofurantoin 100 mg modified-release twice a day for 3 days (if eGFR ≥45 ml/min), or trimethoprim 200 mg twice a day for 3 days (if low risk of resistance).	Trimethoprim is a poor empirical choice after recent trimethoprim use or a previous trimethoprim-resistant culture.
Lower UTI — second choiceNG109: not improving after ≥48 h, or first choice unsuitable	Nitrofurantoin (if not used first and eGFR ≥45); pivmecillinam 400 mg initial dose then 200 mg three times a day for a total of 3 days; or fosfomycin 3 g single dose.	Send an MSU if not already sent and use the result to guide further treatment.
Lower UTI in pregnancyNG109, 7 days	Immediate prescription after an MSU. First choice nitrofurantoin 100 mg MR twice a day for 7 days (avoid at term). Second choice amoxicillin 500 mg three times a day for 7 days (only if culture-susceptible) or cefalexin 500 mg twice a day for 7 days.	Treat asymptomatic bacteriuria in pregnancy on the culture result. Trimethoprim is not an NG109 pregnancy option and is avoided in the first trimester (folate antagonist — SPC).
Acute pyelonephritis, non-pregnant 16+NICE NG111	Cefalexin 500 mg twice or three times a day for 7–10 days (if severe infection is suspected, seek hospital/specialist advice rather than escalating the oral dose); co-amoxiclav 500/125 mg three times a day for 7–10 days or trimethoprim 200 mg twice a day for 14 days only if culture-susceptible; ciprofloxacin 500 mg twice a day for 7 days only if other choices unsuitable (MHRA fluoroquinolone warnings).	MSU before antibiotics. Never nitrofurantoin for the upper tract. Refer if signs of serious illness; consider referral if pregnant, dehydrated or unable to take oral treatment.
Recurrent UTI — rung 2NICE NG112	Vaginal oestrogen for postmenopausal women if behavioural measures alone are not effective or not appropriate; review within 12 months. Product and regimen per SPC.	Do not offer systemic HRT to reduce UTI risk. Check breast cancer history (NG23).
Recurrent UTI — rung 3NG112, non-pregnant	Single-dose prophylaxis at an identifiable trigger (e.g. trimethoprim 200 mg or nitrofurantoin 100 mg if eGFR ≥45; second choice amoxicillin 500 mg or cefalexin 500 mg).	Review single-dose prophylaxis within 6 months.
Recurrent UTI — rung 4NG112, non-pregnant	Methenamine hippurate (2024 update) as an alternative to daily antibiotic prophylaxis once the current UTI has been treated — dose per SPC; review within 6 months then every 12 months. Or daily prophylaxis: trimethoprim 100 mg at night (low risk of resistance) or nitrofurantoin 50–100 mg at night (eGFR ≥45); second choice amoxicillin 250 mg or cefalexin 125 mg at night.	Explain resistance and adverse-effect risks; review within 6 months and consider stopping. Choose on the most recent culture.

Where does a standby supply fit? It is not a step on the NG112 ladder. In a small number of women — culture-confirmed recurrences, a known sensitive organism, good understanding and a way to drop off a sample — some local guidance supports a self-start course, usually after specialist advice and always with a sample taken before starting and a review arrangement. For Janet today it would be premature: most episodes were unconfirmed, the haematuria is unexplained, and the prevention ladder has not been tried.

7D (continued) — Acute episode and prevention at a glance

💊 Antibiotic choice

Situation	Choice
Uncomplicated lower UTI	Nitrofurantoin 100mg MR BD for 3 days (first-line if eGFR ≥45); alternative trimethoprim 200mg BD 3 days where resistance low; second-line per local guidance/culture.
Pyelonephritis (oral)	Cefalexin (or per local guidance) for 7–10 days; send culture; review; admit if unwell/vomiting/pregnant.
Pregnancy	Always treat (and screen/treat asymptomatic bacteriuria); MSU before antibiotics; immediate 7-day course (NG109); avoid trimethoprim in 1st trimester, avoid nitrofurantoin at term.
Self-care for symptoms	Fluids, analgesia (paracetamol/NSAID); evidence for cranberry/alkalinisers is limited — don't oversell.

🛡️ Prevent recurrence

Measure	Detail
Vaginal oestrogen	Post-menopausal recurrent UTI — one of the most effective measures; topical, minimal systemic absorption.
Behavioural / self-care	Adequate fluids; treat constipation; address triggers (spermicide/diaphragm); post-coital voiding where a pattern exists; don't over-rely on cranberry.
Prophylaxis	Where episodes are frequent and culture-confirmed: single-dose post-coital antibiotic (if post-coital pattern) or continuous low-dose prophylaxis with review; consider the non-antibiotic option methenamine hippurate (NICE NG112, 2024 update) before daily antibiotics.
Self-start (standby)	Only for selected patients with proven recurrent culture-confirmed UTI, with a clear plan and safety-net — not a blanket back-pocket prescription.

7F — Drug reference cards: UTI treatment and prevention

Nitrofurantoin

Modified-release capsules · immediate-release tablets/capsules

✓ First choice — lower UTI

First-line (NG109)100 mg MR BD × 3 days (7 days in pregnancy) — eGFR ≥45

✓ Prefer when

Uncomplicated lower UTI in a non-pregnant woman with eGFR ≥45 (NG109) — low resistance rates and little collateral effect on gut flora

Lower UTI in pregnancy (7 days) — but not at term (NG109)

Single-dose (100 mg) or nightly (50–100 mg) prophylaxis under NG112 when the rungs below have not worked

✗ Avoid if

Pyelonephritis or any upper-tract / systemic infection — does not achieve useful kidney tissue levels (NG111)

eGFR <45 — except a cautious short course at 30–44 for suspected or proven multidrug-resistant organisms when benefit outweighs risk (SPC)

At term in pregnancy — risk of neonatal haemolysis (NG109)

G6PD deficiency, acute porphyria, and other contraindications per SPC

⚠ Side effects

Nausea (take with food); urine may turn dark yellow or brown — harmless

Pulmonary reactions can occur with short- or long-term use (acute reactions usually in the first week; chronic fibrosis with long-term use); hepatic reactions and peripheral neuropathy, mainly with longer use — MHRA Drug Safety Update (April 2023) asks prescribers to be vigilant for new or worsening pulmonary or hepatic symptoms

🔬 Monitor

eGFR before prescribing (especially older women). For long-term prophylaxis: ask about cough, breathlessness and jaundice at each review; liver and lung monitoring per SPC / local guidance; stop if they occur

💬 Counselling

"Take it with food, twice a day, for three days. It can turn your urine a darker colour — that's the tablet, not blood. If you get a temperature, shivers or pain in your back, this tablet isn't strong enough for a kidney infection, so contact us the same day."

SCA phrase: "I'm choosing a tablet that concentrates in the bladder, where the infection is — three days is enough for a bladder infection. Before you take the first one, I'd like a urine sample so the lab can tell us exactly which germ it is."

Trimethoprim

Tablets · oral suspension

✓ First choice if low resistance risk

First-line alternative (NG109)200 mg BD × 3 days (lower UTI)

✓ Prefer when

Low risk of resistance — no recent trimethoprim and no previous trimethoprim-resistant culture (NG109)

Nitrofurantoin unsuitable (eGFR, intolerance) and culture shows susceptibility

NG112 prophylaxis: 200 mg single dose at a trigger, or 100 mg at night, if low resistance risk

✗ Avoid if

First trimester of pregnancy — folate antagonist (SPC); not an NG109 pregnancy option

Taking methotrexate — additive folate antagonism and marrow toxicity

Hyperkalaemia risk: CKD, ACE inhibitor, ARB, spironolactone — check potassium; blood dyscrasias; other cautions per SPC

⚠ Side effects

Nausea, rash, itch; raised potassium; small rise in serum creatinine (reduced tubular secretion, not true loss of kidney function)

🔬 Monitor

Potassium and renal function if at risk of hyperkalaemia. Previous culture results before each prescription — resistance is common

💬 Counselling

"Twice a day for three days. If you are on any blood pressure or heart tablets, or methotrexate, tell me — this one can interact. If you might be pregnant, let me know, because I'd choose something else."

SCA phrase: "You've had several antibiotics this year, so I don't want to guess — the lab result from your last infection tells me which ones will still work."

Pivmecillinam · Fosfomycin

Pivmecillinam tablets · fosfomycin trometamol 3 g granules

✓ Second choice — lower UTI

Second-line (NG109)Pivmecillinam 400 mg then 200 mg TDS (total 3 days) · Fosfomycin 3 g single dose

✓ Prefer when

No improvement after at least 48 hours on a first-choice drug, or first choice unsuitable (NG109)

Culture shows resistance to nitrofurantoin and trimethoprim but susceptibility to these agents

✗ Avoid if

Pivmecillinam: penicillin allergy — it is a penicillin

Pivmecillinam: carnitine deficiency and oesophageal strictures (swallow upright with plenty of water) — per SPC. Fosfomycin: severe renal impairment — per SPC

Neither is appropriate for pyelonephritis

⚠ Side effects

Nausea, diarrhoea; vulvovaginal candidiasis; rarely Clostridioides difficile infection

🔬 Monitor

Symptom response at 48 hours; act on the culture result; persisting symptoms → reconsider diagnosis or upper tract

💬 Counselling

"Fosfomycin is one sachet, dissolved in water, taken once — ideally at bedtime after emptying your bladder, on an empty stomach. Pivmecillinam is taken with plenty of water while sitting or standing, with or just after food."

SCA phrase: "The first tablet hasn't done the job, so I'm switching to a different family of antibiotic and I'll check the lab result as soon as it's back to be sure it's the right one."

Cefalexin

Capsules · tablets · oral suspension

✓ First oral choice — pyelonephritis

Upper UTI (NG111) · pregnancy 2nd choice (NG109)Pyelonephritis: 500 mg BD–TDS × 7–10 days · Pregnancy lower UTI: 500 mg BD × 7 days

✓ Prefer when

Acute pyelonephritis managed in the community (NG111) — if severe infection is suspected, seek hospital/specialist advice rather than escalating the oral dose

Lower UTI in pregnancy when nitrofurantoin is unsuitable, e.g. at term (NG109)

Second-choice nightly prophylaxis (125 mg) under NG112

✗ Avoid if

History of immediate (anaphylactic) penicillin or cephalosporin allergy — cross-sensitivity; seek alternative per SPC / microbiology

Renal impairment — dose adjustment per SPC

⚠ Side effects

Diarrhoea, nausea; thrush; C. difficile risk (broader spectrum than nitrofurantoin — reserve for the upper tract or where needed)

🔬 Monitor

Pyelonephritis: MSU before starting; reassess at 48 hours (NG111); refer if not improving; change agent on culture result

💬 Counselling

"This is a stronger antibiotic that reaches the kidneys. Take the full course even when you feel better. If you're being sick and can't keep it down, or you feel worse after two days, you need to be seen the same day."

SCA phrase: "Because the fever and back pain tell me this has reached the kidney, the three-day bladder tablet isn't enough — you need a week or more of an antibiotic that gets into the kidney."

Vaginal oestrogen

Estriol cream · estradiol 10 microgram vaginal tablets · estradiol-releasing vaginal ring

✓ Recommended — postmenopausal recurrent UTI

NG112 rung 2Dose per SPC and local formulary (typically daily for 2 weeks, then twice weekly; ring 3-monthly)

✓ Prefer when

Postmenopausal woman with recurrent UTI where behavioural measures alone are not effective or not appropriate (NG112) — Janet

Coexisting genitourinary syndrome of menopause (dryness, soreness, dyspareunia, urgency)

Wants a non-antibiotic option first

✗ Avoid / specialist discussion

Undiagnosed vaginal or postmenopausal bleeding — investigate first

History of breast cancer: non-hormonal moisturisers/lubricants first, then consider vaginal oestrogen if symptoms continue; if on an aromatase inhibitor, decide with the breast cancer specialist (NICE NG23)

Use for recurrent UTI is off-label for vaginal oestrogen products (NG112) — explain and document

⚠ Side effects

Local irritation, discharge or mild breast tenderness early on; minimal systemic absorption at low doses

🔬 Monitor

Review within 12 months (NG112): recurrences, tolerance, still needed? Any postmenopausal bleeding → investigate. Benefit tends to fade if stopped — discuss long-term use

💬 Counselling

"This isn't like HRT tablets — it's a tiny dose that works on the tissues just where it's needed and barely gets into the bloodstream. Use it every night for two weeks, then twice a week to keep the tissues healthy. It takes a few weeks to build up, and it only keeps working while you use it."

SCA phrase: "After the menopause the skin around the bladder gets thinner and loses its natural protection, which lets germs in more easily. A small amount of oestrogen used vaginally puts that protection back — and for many women it reduces infections without any antibiotic."

Methenamine hippurate

Tablets

✓ Non-antibiotic alternative to daily prophylaxis

NG112 rung 4 (2024)Dose per SPC and local formulary (usually 1 g twice a day)

✓ Prefer when

Recurrent UTI not adequately improved by behavioural measures, vaginal oestrogen (postmenopausal) or single-dose prophylaxis, as an alternative to daily antibiotic prophylaxis (NG112, updated December 2024)

Non-pregnant, and the current UTI has been adequately treated first

ALTAR trial (Harding et al, BMJ 2022): non-inferior to daily low-dose antibiotic prophylaxis over 12 months, with less antibiotic resistance in urinary E. coli than in the antibiotic arm

✗ Avoid / seek specialist advice

Pregnancy, recurrent upper UTI or complicated lower UTI — specialist advice (NG112)

Contraindications per SPC (these include severe renal impairment, severe hepatic impairment, gout, metabolic acidosis and severe dehydration); not for treating an active infection

Needs acidic urine — avoid urinary alkalinising products (e.g. potassium citrate) at the same time

⚠ Side effects

Nausea, dyspepsia, rash; bladder irritation at higher doses

🔬 Monitor

Review within 6 months, then every 12 months (NG112): recurrence rate, tolerability, still needed. Renal function per SPC

💬 Counselling

"This isn't an antibiotic. It turns into a mild antiseptic in the bladder that stops germs settling, so germs don't become resistant to it. Take it twice a day, every day. It prevents infections — it won't treat one that's already started, so still contact us if symptoms come back."

SCA phrase: "If the oestrogen isn't enough on its own, there's a daily tablet that works as a bladder antiseptic rather than an antibiotic — a big trial found it prevented infections about as well as low-dose antibiotics."

7G — Psychosocial impact: sleep, intimacy, work and caring, the cancer question, and identity

🤝

Recurrent UTI — a "minor" infection that quietly reorganises a woman's life

Each episode is short, but the pattern is not. Women with recurrent UTI often plan their days around toilets, avoid travel and intimacy, sleep badly, and carry a background anxiety about the next attack. For Janet, a new layer arrives today: an urgent referral that she may hear as "cancer". A plan that addresses only the antibiotic misses most of what the recurrence costs her.

😴

Sleep and daily function

Frequency, urgency and new nocturia fragment sleep during every episode, and fear of the next one can keep women close to a toilet. Fatigue lowers resilience and feeds the wish for a quick fix.

"How much are these affecting your sleep and what you can do in the day? That helps me understand how much of a priority prevention should be."

💞

Intimacy and relationships

Vaginal dryness and fear of triggering an infection lead many postmenopausal women to avoid sex, sometimes without discussing it with anyone. Janet is not sexually active now — ask gently whether that is by choice or because of symptoms, as vaginal oestrogen may help both.

"Some women find these infections, or dryness after the menopause, put them off intimacy. Is that something that's been an issue for you? The treatment I'm suggesting can help with that too."

👵

Work, volunteering and caring

Janet is a retired teaching assistant; many women of her age care for grandchildren or older parents, volunteer, or work part-time. Urgency makes school runs, car journeys and long shifts difficult, and repeated episodes lead to cancelled commitments and guilt.

"Are you looking after anyone — grandchildren, a parent? I want to make sure the plan works around the things you need to be able to do."

🎗️

The cancer question

An urgent suspected cancer referral is frightening even when framed well. Janet may go home, search online and assume the worst — or minimise it and not attend. Be honest that it is a cancer-exclusion pathway, that most people referred do not have cancer, and what the tests involve (usually a camera test of the bladder and a scan).

"This is the fast-track route used to rule out anything serious. Most people who go through it don't have cancer, but it's the quickest way to be sure. You'll be seen quickly and should get an answer within 4 weeks — please don't miss the appointment, and ring me if you're worried while you wait."

🚗

Driving and travel

Uncomplicated UTI has no DVLA notification requirement. The practical issue is urgency on journeys and not driving while feverish, drowsy or unwell. In older or frail women, a UTI-related delirium is a reason not to drive until fully recovered — that is general fitness-to-drive advice, not a notifiable condition.

"There's nothing to tell the DVLA about with a water infection. Just don't drive if you feel feverish, shivery or muddled — and plan loo stops on longer journeys while this settles."

👤

Menopause, ageing and identity

Being told recurrent infections relate to menopause can feel like an unwelcome label of ageing, and the word "hormones" may alarm women who have heard mixed messages about HRT. Normalise genitourinary syndrome of menopause as common and treatable, and make clear that vaginal oestrogen is not systemic HRT.

"This is really common after the menopause — it's not something you've done wrong, and it's very treatable. The oestrogen I'm suggesting is a local treatment, not HRT tablets."

7H — Follow-up schedule

Day 0 — Treat, sample, refer, start prevention

MSU sent before the first dose. Nitrofurantoin 3 days (eGFR ≥45) or an agent chosen on previous culture. Vaginal oestrogen started (breast cancer history checked). Urgent suspected cancer referral for persistent visible haematuria (NG12), with eGFR/U&E if the local pathway requests it. HbA1c. Written safety-net and prevention plan.

Suspected cancer pathway referral sent same dayMSU before antibiotic

48–72 hours — Response and culture result

Not starting to improve within 48 hours, or worse at any time → reassess (NG109): second-choice antibiotic guided by the culture, consider upper UTI or another diagnosis. Culture shows resistance to the drug given and still symptomatic → switch to a susceptible agent. Record the organism and sensitivities prominently for future episodes.

48-hour ruleCulture actioned

1–2 weeks — Haematuria check and referral confirmed

Urinalysis after treatment to document whether blood has cleared — this does not delay or replace the referral already made for visible haematuria. Confirm Janet has an appointment and knows what to expect. Safety-net for any further visible blood.

Referral attended?Dipstick after treatment

6–12 weeks — Prevention review

Recurrences since starting vaginal oestrogen? Technique and adherence. Reversible drivers addressed (constipation, fluids, emptying — bladder scan if residual suspected; HbA1c result). Outcome of the urology assessment. If infections continue despite behavioural measures and vaginal oestrogen → discuss the next NG112 rungs (single-dose prophylaxis if there is a trigger, then methenamine), based on culture results.

NG112 ladderUrology outcome

6 and 12 months — Structured reviews

Methenamine or antibiotic prophylaxis: review within 6 months (NG112) — consider stopping, check resistance and adverse effects; methenamine then every 12 months. Vaginal oestrogen: review within 12 months. If recurrent lower UTI persists with no cause found, or any relapse with the same organism, stones or structural concern → urology / specialist advice (NG112).

6-month prophylaxis review12-month oestrogen review

7I — Monitoring: infection markers, drug safety and prevention outcomes

Memory rule — recurrent UTI monitoring

At every contact: count the episodes (culture-confirmed or not); culture each new episode before treating; check the blood — visible haematuria outlasting infection at 45+ is a referral, not a re-treat; check the kidneys — eGFR before nitrofurantoin; review dates — 6 months for prophylaxis and methenamine, 12 months for vaginal oestrogen.

What	Test / question	Timing	Action threshold
Each episode	MSU culture and susceptibility	Before antibiotics in recurrent UTI, pregnancy, ≥65, suspected pyelonephritis, treatment failure	Resistant organism and still symptomatic → change to a susceptible agent. Same organism relapsing within about 2 weeks → think stone, structural cause, incomplete treatment
Haematuria	History of visible blood; urinalysis after treatment	After each treated episode	Visible haematuria persisting or recurring after successful UTI treatment at ≥45 → urgent suspected cancer referral. Non-visible haematuria at ≥60 with dysuria or raised WCC → urgent referral (NG12)
Renal function	eGFR, U&E	Before nitrofurantoin if not recent; with long-term prophylaxis per SPC	eGFR <45 → avoid nitrofurantoin (SPC exception at 30–44 for MDR organisms). Rising potassium on trimethoprim → review
Glycaemia	HbA1c	Once in the recurrent UTI work-up	Diabetes found → manage; UTI becomes "complicated" — lower threshold for culture and review
Emptying	Post-void residual bladder scan	If symptoms or examination suggest incomplete emptying	Significant residual → look for cause (prolapse, constipation, neurological, drugs); urology / urogynaecology if needed
Nitrofurantoin (long term)	Cough, breathlessness, jaundice, neuropathy; LFTs per local guidance	At each review	New pulmonary or hepatic symptoms → stop and investigate (MHRA DSU April 2023)
Vaginal oestrogen	Recurrences; any vaginal bleeding	Within 12 months (NG112)	Postmenopausal bleeding → investigate. Effective → continue with review
Methenamine / antibiotic prophylaxis	Recurrence count, adverse effects, resistance on cultures	Within 6 months; methenamine then every 12 months (NG112)	No benefit or adverse effects → stop; breakthrough infection → culture and treat on sensitivities

7J — Safety-netting: exact phrases, RAG marking and danger zones

Safety-net: "Come back urgently if you develop fever, shivers, back/side pain, vomiting, or feel very unwell — that can mean the infection has reached the kidney." Close the loop on the culture result and the suspected cancer pathway referral. Review the prevention plan and vaginal oestrogen response in a few weeks. Stewardship: avoid treating asymptomatic bacteriuria (except pregnancy); base any prophylaxis/self-start on culture.

⚠ Three scenario-specific safety-nets — use these verbatim

What to document

Symptoms, absence of systemic features and vaginal symptoms, observations, loin tenderness — the basis for "lower UTI"

Episode count and culture history; recurrent UTI named (NG112 definition); MSU sent before antibiotic

Antibiotic, dose and duration with the reason for choice (eGFR, previous cultures, resistance risk)

Haematuria history (timing relative to treatment), urgent suspected cancer referral made, patient informed and how to chase it

Standby-antibiotic request discussed; reasons given; prevention plan agreed (vaginal oestrogen, off-label use explained; behavioural advice)

Specific safety-net given (sepsis, pyelonephritis, 48-hour rule, further haematuria) and written information provided; review booked

48 hoursResponse to antibiotic; culture result actioned

1–2 weeksReferral appointment confirmed; urinalysis after treatment

6–12 weeksPrevention review; urology outcome; next NG112 rung if needed

💭 Why it keeps coming back

"After the menopause the tissues around the bladder get thinner and lose their natural protection, so germs from the skin get in more easily. That's why this keeps happening — and it's also why there's something we can do about it."

😟 The blood — honest, not alarming

"The pink colour after the antibiotics had finished is the one thing I don't want to put down to infection. Most of the time these checks find nothing serious, but at your age the right thing is a quick specialist look, and that's what I've arranged."

🎯 The standby request

"I'm not saying never to having something at home — I'm saying not yet. Let's get your urine tested, start the prevention, and get the bladder checked. If you're still getting infections after that, we'll look at a longer-term plan based on what the lab shows."

🛑 "It's just the infection, isn't it?"

"It may well be. But blood that stays after an infection has been treated is exactly the situation the guidance says should be checked, and I'd rather be thorough than have you wondering. It's a precaution, not a diagnosis."

💊 Vaginal oestrogen

"It's a tiny dose used locally — not HRT tablets. It barely reaches the bloodstream, and it helps the tissues protect themselves again. Every night for two weeks, then twice a week."

📋 Closing the loop

"So: a urine sample now, three days of tablets, the oestrogen tonight, a fast-track referral for the blood, and I'll see you in about six weeks. Fever, back pain or feeling very unwell — same day. Blotchy skin, confusion or no urine — 999. Does that plan work for you?"

Tasks

🟢

Lower UTI confirmed and localised; recurrent UTI named; MSU before antibiotic; nitrofurantoin 3 days with eGFR/culture reasoning; persistent visible haematuria at 58 → urgent suspected cancer referral; vaginal oestrogen with breast cancer check; reversible drivers and HbA1c; specific safety-net; review dates

🟠

Episode treated appropriately but no culture; prevention mentioned without a concrete plan; haematuria noted but "recheck the dipstick first" instead of referring; safety-net generic ("come back if worse")

🔴

Standby antibiotics handed over without assessment; haematuria missed or attributed to infection; nitrofurantoin for fever and loin pain; dipstick-led diagnosis in place of history; no safety-net

Relating to Others

🟢

Frustration validated first; standby request explored ("how did you imagine it working?") and reshaped; referral framed as thoroughness with honest reassurance; vaginal oestrogen explained without jargon; shared plan agreed; closing check

🟠

Explains well but does not return to Janet's request; referral mentioned without exploring her reaction; prevention options listed rather than chosen together

🔴

Flat refusal ("we don't do that"); lecture on antimicrobial resistance; "cancer" used abruptly or referral not explained; patient leaves without a plan

Danger zones — where recurrent UTI consultations go wrong

"Blood in the urine with a UTI — just re-treat"

Visible haematuria that persists or recurs after successful UTI treatment at ≥45 is an urgent suspected cancer referral (NG12). A clear dipstick later does not cancel it

A stash of antibiotics for "next time"

Culture first, work through the NG112 prevention ladder, and review. A self-start supply, if ever used, rests on culture results and usually specialist advice

Nitrofurantoin for fever and loin pain

Pyelonephritis needs an NG111 regimen (e.g. cefalexin 7–10 days) and an MSU. Nitrofurantoin does not reach the kidney

Dipsticking an 80-year-old with delirium

UKHSA 2025: no dipstick at ≥65 or with a catheter. Diagnose on new urinary symptoms and systemic signs; look for other causes of delirium

Nightly antibiotics on unconfirmed "UTIs"

Confirm with cultures, fix reversibles, offer vaginal oestrogen (postmenopausal), then single-dose prophylaxis (if a trigger) and methenamine before daily antibiotics — each with a review date

Trimethoprim in early pregnancy; 3 days in pregnancy

Pregnancy: MSU, immediate 7-day course — nitrofurantoin first (avoid at term), amoxicillin if susceptible or cefalexin (NG109)

Ignoring vaginal discharge

Dysuria with discharge or itch is vaginitis or an STI until shown otherwise — examine, swab, test, and don't reflex-prescribe for UTI

Offering HRT tablets to prevent UTIs

NG112: do not offer systemic HRT to reduce recurrent UTI. Vaginal oestrogen is the evidence-based option

Referral made, never tracked

Log urgent referrals, confirm the appointment, and give the patient a way to chase it — the haematuria safety-net is the one most often lost

🎓 SCA Checkpoint — Step 7TasksRelating to OthersGlobal Skills

A plan that scores

"Here's the plan: a 3-day course for today's infection, a urine sample to the lab, a vaginal oestrogen to cut down how often these happen, simple self-care, and a fast-track referral for the blood. Come back sooner if you get a fever or back pain. We'll review in a few weeks."

Deductions

Standby antibiotics with no plan, no culture, no review
Omitting vaginal oestrogen in a post-menopausal woman with recurrence
No safety-net for pyelonephritis; no follow-up of the suspected cancer pathway referral

"It's another water infection, doctor — that's the fourth this year. The antibiotics work but it just keeps coming back. Can you just give me a few to keep at home so I can start them the moment it flares?"

Who you are

Janet Okafor, 58, retired teaching assistant. Burning on passing urine, going more often, lower tummy ache for two days. You feel well otherwise — no fever, no back pain, not being sick. You went through the menopause about six years ago. Not currently sexually active. You're fed up: this is the fourth episode this year and you keep getting antibiotics from the pharmacy or out-of-hours. You came in mainly to get "a stash" of antibiotics to keep at home. If asked specifically, you remember the urine looked "a bit pink" once last month — and that was after the antibiotics had finished, which you thought was odd but didn't worry about.

Hidden concerns (reveal if explored)

Frustration (main): you feel no one has tried to stop these happening — just treated each one. If the doctor offers a real prevention plan you're relieved and engaged.

The blood (only if asked): you haven't worried about it, but if the doctor explains calmly why a check is sensible, you accept it — though you might ask "it's nothing serious, is it?" and want honest reassurance.

Vaginal oestrogen: if offered, you're a little surprised ("hormones? for water infections?") but open once it's explained.

Clinical details if asked

Dysuria, frequency, urgency, suprapubic ache; no fever, no loin pain, no nausea/vomiting
No vaginal discharge, itch or soreness; not sexually active currently
Four episodes this year; a couple confirmed with urine samples, a couple just treated
Visible pink urine once last month, after the course finished; none since that you've noticed
No diabetes known; not pregnant (post-menopausal); no catheter; empties okay as far as you know
Otherwise well; no weight loss; on no regular medication

Reactions at key moments

On the standby request: "So can I have some to keep, then?" → satisfied if offered a proper plan (and, if standby, one based on a urine test).
On the urine sample/referral: accept once explained; may ask why a referral if "it's just a water infection."
On vaginal oestrogen: "Will that really help?" → accept once mechanism explained.
Challenge line: "I don't see why I need to see a specialist — it's only a water infection like always."

"Honestly doctor, I just want the antibiotics. Why are you making a fuss about a bit of blood — it's just the infection, isn't it?"

Resolution: Janet leaves satisfied if the GP: (1) treats today's infection appropriately; (2) recognises recurrent UTI and offers a prevention plan including vaginal oestrogen and self-care; (3) handles the standby-antibiotic request thoughtfully rather than simply refusing; (4) recognises the persistent visible haematuria in a 58-year-old and arranges a suspected cancer pathway referral, framed sensitively; (5) safety-nets for pyelonephritis and arranges follow-up. She disengages if the blood is dismissed as "just the infection," if she's handed standby antibiotics with no plan, or if her frustration is ignored.

🏥

Clinic Quick Reference

UTI in Women — Clinical Decision Framework

NICE NG109 · Uncomplicated & recurrent · Haematuria red flag (NG12)

▼expand

🚦 1 — Triage first

Woman with dysuria/frequency

▼

🔴 Same-day

Sepsis / systemic upset
Pyelonephritis: vomiting / pregnant / not coping
Obstructed infected system

Admit

🟠 Suspected cancer pathway referral · NG12

Visible haematuria 45+ (no UTI / persists after Rx)
Non-visible haematuria 60+ + dysuria/raised WCC

Bladder suspected cancer pathway referral

🟢 Routine

Uncomplicated lower UTI
Recurrent UTI — prevention
?Vaginal/STI cause

GP manage

💊 2 — Treat & prevent

Acute

Nitrofurantoin 100mg MR BD 3 days (eGFR ≥45) first-line. Don't dipstick over-65/catheter. Culture if recurrent/pregnant/failure/atypical. Pyelonephritis: cefalexin 7–10 days; admit if unwell/vomiting/pregnant. Pregnancy: always treat/culture; drug cautions.

Recurrent (≥2/6mo or ≥3/yr)

Vaginal oestrogen (post-menopausal); self-care (fluids, constipation, triggers); post-coital or continuous prophylaxis (culture-guided, reviewed) ± non-antibiotic options. Exclude haematuria red flag + incomplete emptying.

🎓

SCA Quick Reference

UTI in Women — Consultation Playbook

Treat · prevent · steward · don't miss the haematuria

▼expand

🎯 The three pivots that pass this case

1 · The red flag

Visible haematuria 45+ that outlasts the UTI → NICE NG12 suspected bladder cancer pathway referral. Don't just re-treat.

2 · Prevent, don't just treat

Recurrent UTI: vaginal oestrogen (post-menopausal), self-care, considered prophylaxis — not endless reactive courses.

3 · The request

Reshape the standby-antibiotic ask: culture-guided, with a plan and safety-net — not a blind back-pocket prescription.

⛔ Don't attribute persistent visible blood to "recurrent cystitis" · Don't dipstick over-65s/catheters or treat asymptomatic bacteriuria (except pregnancy) · Don't forget vaginal oestrogen post-menopause · Don't hand over standby antibiotics with no assessment · Always safety-net for pyelonephritis

UTI in Women · GP Clinical Reasoning Framework v2 · NICE NG109 Urinary tract infection (lower) · NICE NG112 (recurrent) · NICE NG12 Suspected cancer (updated April 2026; bladder — haematuria) · NICE NG111 Pyelonephritis (acute) · NICE NG253 / NG255 Suspected sepsis (2025) · NICE NG23 Menopause · UKHSA UTI diagnostic tools (2025) · NHS England Pharmacy First · UKHSA (formerly PHE) antimicrobial guidance

≥2 key signs (dysuria, new nocturia, cloudy urine), no vaginal symptoms → treat (nitrofurantoin 3 days, eGFR ≥45) · Don't dipstick over-65/catheter; avoid treating asymptomatic bacteriuria except in pregnancy · Recurrent = ≥2/6mo or ≥3/yr → vaginal oestrogen + self-care + considered prophylaxis · Visible haematuria 45+ without UTI or persisting after treatment → NG12 suspected bladder cancer pathway referral · Pyelonephritis = systemic features → culture + 7–10 days ± admission · Pregnancy → always treat & culture; drug cautions

Teaching clinicians why each step matters — not just what to do · Always consult current NICE NG109, NG111, NG112 and NG12 guidance · Clinical judgement takes precedence over any framework

UTI in Women

Red Flags — when "another UTI" is something else

🌸 Post-menopausal vaginal atrophy

💊 Antibiotic stewardship vs the standby request

💉 The blood — careful framing

Same day / 999

Suspected cancer pathway referral & specialist

GP Management

🚩 The masquerader — bladder cancer behind "recurrent cystitis"

Validate — name the request and the frustration

Explain — why a blind stash is not the best tool yet

Negotiate — give her something concrete today

Sleep and daily function

Intimacy and relationships

Work, volunteering and caring

The cancer question

Driving and travel

Menopause, ageing and identity

Day 0 — Treat, sample, refer, start prevention

48–72 hours — Response and culture result

1–2 weeks — Haematuria check and referral confirmed

6–12 weeks — Prevention review

6 and 12 months — Structured reviews

Memory rule — recurrent UTI monitoring

⚠ Three scenario-specific safety-nets — use these verbatim

What to document

🎭 Patient actor brief — click to practise

Who you are

Hidden concerns (reveal if explored)

Clinical details if asked

Reactions at key moments